Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine vs Clonidine for Neonatal Abstinence Syndrome
NCT01734551Phase 4Completed
- Start
- Sep 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of clonidine in neonatal abstinence syndrome (NAS) (2 arms). Primary endpoints: Finnegan Neonatal Abstinence Scoring System at 14 days and Duration of Treatment at 120 days. Started Sep 2011; status: completed.
02
Drugs
clonidine
03
Conditions
neonatal abstinence syndrome (NAS)
Beyond the preview
Go deeper on NCT01734551.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01734551.